🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

External Oblique Intercostal Block Versus Transversus Abdominis Plane Combined With Rectus Sheath Block on Postoperative Pain in Laparoscopic Radical Gastrectomy

RecruitingNAAges 18 Years - anyAllGeneral Hospital of Ningxia Medical University
NCT07496086 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Postoperative pain is highly prevalent following laparoscopic radical gastrectomy. Although Transversus abdominis plane block combined with rectus sheath block(TAP+RSB） can effectively alleviate this pain, it still has many limitations. The external oblique intercostal plane block (EOIB) is a novel nerve block technique that may provide well postoperative analgesia for upper abdominal surgery. Therefore, this study employs a non-inferiority randomized controlled trial design to verify that the analgesic effect of EOIB is not inferior to that of ESPB, thereby offering more options for regional analgesia strategies in laparoscopic radical gastrectomy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged over 18 years * Classified as ASA I-III * Scheduled for elective laparoscopic radical gastrectomy under general anesthesia * Voluntarily participated and provided written informed consent. Exclusion Criteria: * Chronic opioid dependence or prior use of analgesic medications for \>3 months; * Inability to communicate due to severe dementia, language barriers, or terminal illness; * History of central and/or peripheral nervous system disorders; * Severe renal insufficiency (serum creatinine \>442 μmol/L or requiring renal replacement therapy) or severe hepatic insufficiency (Child-Pugh class C); * Allergy to local anesthetics. * Expected to be transferred to ICU after surgery. * Refuse patient control agenesia after surgery.
💊

What it tests

  • EOIB
  • TAP+RSB
📍

Where

1 site
General hospital of Ningxia medical university
Yinchuan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy